Aliases: ApoB-100.
APOB (apolipoprotein B) is named by 5 disorder entries. It encodes apolipoprotein B, the structural protein of chylomicrons, VLDL and LDL particles.
The pinned ai-gene-review snapshot that the ingest layer reads has no core functions for APOB (0 terms). An upstream review of the gene is being added or updated.
The entries that type APOB as causative are Familial Defective Apolipoprotein B-100; Hypobetalipoproteinemia, and the germline-origin causative entries are Familial Defective Apolipoprotein B-100; Hypobetalipoproteinemia. ClinGen rates the gene definitive for familial defective apolipoprotein B-100 and definitive for hypobetalipoproteinemia.
In Familial Defective Apolipoprotein B-100 the gene sits on the nodes APOB Receptor-Binding-Region Missense Variant and Defective ApoB-100 Binding to a Structurally Normal LDL Receptor. In Hypobetalipoproteinemia it sits on APOB Truncating Variant and Impaired Hepatic and Intestinal ApoB-Lipoprotein Assembly and Secretion. The KB's mechanism annotations for APOB name the processes cholesterol metabolic process; low-density lipoprotein particle clearance; receptor-mediated endocytosis; very-low-density lipoprotein particle assembly.
MEND Syndrome records APOB as modifier. The entries with a genetic record for APOB that carries no relationship type are Familial Hypercholesterolemia; Hyperlipidemia.
Because the pinned ai-gene-review snapshot has no core functions for the gene, the KB and ai-gene-review currently share 0 GO process terms.
Underlined values are claims re-computed from the knowledge base each time this page is built. The tables below are the source of truth.
Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.
| Disorder | Relationship | Where the gene appears |
|---|---|---|
| Familial Defective Apolipoprotein B-100 |
causative
germline
partial loss of function
CLINGEN: definitive
|
mechanism: APOB Receptor-Binding-Region Missense Variant; Defective ApoB-100 Binding to a Structurally Normal LDL Receptor
|
| Hypobetalipoproteinemia |
causative
germline
loss of function
CLINGEN: definitive
|
mechanism: APOB Truncating Variant; Impaired Hepatic and Intestinal ApoB-Lipoprotein Assembly and Secretion
subtype: FHBL1 Heterozygous; FHBL1 Homozygous
diagnosis: APOB molecular genetic testing
|
| MEND Syndrome | modifier | |
| Familial Hypercholesterolemia |
untyped
Pathogenic Mutations
|
mechanism: APOB-LDLR Binding Defect
treatment: Mipomersen
|
| Hyperlipidemia |
untyped
Monogenic Cause and ApoB-Trafficking Determinant
|
mechanism: Impaired Hepatic ApoB-Containing Lipoprotein Clearance
|
An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.
| ClinGen disease | MOI | Classification | dismech entry |
|---|---|---|---|
| hypercholesterolemia, autosomal dominant, type B MONDO:0007751 | AD | Definitive 2018-11-14 |
Familial Defective Apolipoprotein B-100
causative
|
| familial hypobetalipoproteinemia 1 MONDO:0014252 | SD | Definitive 2020-02-26 |
Hypobetalipoproteinemia
causative
|
Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.